Belhaven Biopharma | Finanzwire

Basculer en Français

9527	Companies
187412	Keywords
119446	Articles
100176	Press releases

Home
Companies
Belhaven Biopharma

BRIEF

published on 07/09/2024 at 17:05, 1 year 5 months ago

Belhaven Biopharma Study Shows Promising Results for Nasal Epinephrine Delivery

Belhaven Biopharma Nasdepi Anaphylaxis Treatment Medical Research Nasal Epinephrine
PRESS RELEASE

published on 07/09/2024 at 17:00, 1 year 5 months ago

New Canine Study From Belhaven Biopharma Supports Dry Powder Nasal Epinephrine Delivery Solution
Belhaven Biopharma presents promising results of Nasdepi Canine Study at Respiratory Drug Delivery 2024, indicating faster & effective treatment for anaphylaxis. Intranasal dry powder epinephrine offers breakthrough prospects in emergency care for severe allergies

Belhaven Biopharma Anaphylaxis Treatment Nasdepi Canine Study Dry Powder Nasal Solution Respiratory Drug Delivery 2024
PRESS RELEASE

published on 02/08/2024 at 18:30, 1 year 10 months ago

Belhaven Biopharma Announces Groundbreaking Clinical Results for Nasdepi, the Revolutionary Nasal Dry Powder Epinephrine Product
Belhaven Biopharma shares positive results from Phase 1 clinical trial of Nasdepi, a nasal dry powder epinephrine device for treating anaphylaxis. Successful investor round and Series A financing on the horizon

Phase 1 Clinical Trial Series A Financing Belhaven Biopharma Nasdepi Anaphylaxis Treatment
PRESS RELEASE

published on 11/28/2023 at 19:30, 2 years ago

Belhaven Biopharma Achieves Significant Milestones in Advancing Nasdepi - a Revolutionary Nasal Dry Powder Epinephrine Product

Accesswire

Published on 12/15/2025 at 15:00, 1 hour 10 minutes ago

Kingfisher Reports Annual General Meeting Voting Results
Published on 12/15/2025 at 15:00, 1 hour 10 minutes ago

Jaguar Health Announces Abstract Submission for Preliminary Data from US Investigator-Initiated Trial of Crofelemer in Adult Patients with Short Bowel Syndrome with Intestinal Failure (SBS-IF)
Published on 12/15/2025 at 14:30, 1 hour 40 minutes ago

Unusual Machines Congratulates Customers Selected for the Army's PBAS Tranche 1.1, Including Envision Technology and Strategic Logix
Published on 12/15/2025 at 14:00, 2 hours 10 minutes ago

Dateline Delivers Further High-Grade Intercepts from North Pipe at Colosseum
Published on 12/15/2025 at 13:30, 2 hours 40 minutes ago

Greenlane Announces Results of Annual Meeting of Stockholders, Canopy Growth Co Founder Bruce Linton Joins Greenlane's Board of Directors

View all ACCESSWIRE

EQS Group

Published on 12/15/2025 at 16:08, 2 minutes ago

Conversion of The Platform Group AG into a KGaA completed as planned
Published on 12/15/2025 at 15:50, 20 minutes ago

Original-Research: Cabka N.V. (von First Berlin Equity Research GmbH): Kaufen
Published on 12/15/2025 at 15:49, 21 minutes ago

Mutares submits an irrevocable offer to acquire Venator Ultramarine Blue Pigments business from Venator France SAS
Published on 12/15/2025 at 15:45, 25 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Qualcomm Incorporated
Published on 12/15/2025 at 15:44, 26 minutes ago

Form 8.3 - The Vanguard Group, Inc.: American Axle & Manufacturing Holdings, Inc.

Les Echos

Published on 12/15/2025 at 11:50, 4 hours 20 minutes ago

Statement about the number of shares composing the share capital and the number of voting rights as of November 30, 2025
Published on 12/12/2025 at 18:00, 2 days 22 hours ago

Disclosure of trading in own shares between November 24th and November 28th, 2025
Published on 12/12/2025 at 09:15, 3 days 6 hours ago

CHANGE IN THE SHARE CAPITAL
Published on 12/11/2025 at 19:23, 3 days 20 hours ago

Eiffage is joining the CAC 40 index
Published on 12/11/2025 at 08:30, 4 days 7 hours ago

Edenred and Daimler Truck join forces to accelerate the rollout of charging infrastructure for electric trucks in Europe

View all LES ECHOS COMFI WIRE